2m 2m 2m 2m 2m 2m 2m
CENTURY THERAP (IPSC)
NASDAQ
$2.08+$0.01 (+0.48%)
Price as of Aug 21, 2026 7:30 PM EDT- $374.8MMarket Cap
- 282.48%1-Year Change
- BiotechnologyIndustry
CENTURY THERAP (IPSC)
$2.08+$0.01 (+0.48%)
IPSC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.07 | ||
Change | +$0.05 (+2.48%) | ||
Open | $2.05 | ||
High | $2.08 | ||
Low | $2.02 | ||
Previous Close | $2.02 | ||
Volume | 330,592 | ||
30-Day Average Volume | 558,115 | ||
1-Week Change | 7.81% | ||
1-Month Change | -7.59% | ||
1-Year Change | 282.48% | ||
3-Year Change | -19.77% | ||
5-Year Change | -92.13% | ||
Fundamentals | |||
Shares Outstanding | 181.1M | ||
Total Assets | $287.0M | ||
Market Cap | $374.8M | ||
Enterprise Value | $325.2M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$34.5M | ||
Free Cash Flow | -$20.5M | ||
EBIT | -$34.5M | ||
EBITDA | -$31.9M | ||
Net Working Capital | $109.7M | ||
EPS | -$0.17 | ||
Enterprise Value/EBITDA | -10 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -12 | ||
PEG | 0 | ||
Price/Free Cash Flow | -18 | ||
Price/Operating Cash Flow | -19 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue